
    
      Dose escalation study: Primary purpose: To investigate the safety and tolerability of DP303c
      in subjects with HER2-positive advanced solid tumors . Secondary purpose:1. To characterize
      the pharmacokinetics(PK) profile of DP303c;2. To assess the preliminary anti tumor activity
      of DP303c; 3. To characterize immunogenicity of DP303c.
    
  